Tag: Diseases
-
Google-backed AI drugs to trial by 2026?
Google-backed Isomorphic Labs plans to begin clinical trials for AI-designed drugs by year-end. Using AI technology like AlphaFold, the company targets diseases such as cancer, heart conditions, and neurodegeneration. Other companies, including Insilico Medicine, have already seen success with AI drugs, showing promising results in clinical trials for various conditions.